Suchergebnisse - (Person:"Soy, Mehmet")

PubPharm (12)

1

Factors influencing the course of COVID-19 in the inflammatory rheumatic diseases

enthalten in: Clinical and experimental rheumatology | 2023

von Celik, S. | Kutu, M. | Bal, C. | +3

2

Interleukin-1 Inhibitors and Vaccination Including COVID-19 in Inflammatory Rheumatic Diseases : A Nonsystematic Review

enthalten in: Frontiers in immunology | 2021

von Atagündüz, P. | Keser, G. | Soy, M.

3

Cytokine storm in COVID-19 : pathogenesis and overview of anti-inflammatory agents used in treatment

enthalten in: Clinical rheumatology | 2020

von Soy, M. | Keser, G. | Atagündüz, P. | +3

4

Diagnostic dilemma of paraneoplastic arthritis : case series

enthalten in: International journal of rheumatic diseases | 2014

von Kisacik, B. | Onat, A. | Kasifoglu, T. | +23

5

Intermediate to long-term follow-up results of INH chemoprophylaxis prior to anti-TNF-alpha therapy in a high-risk area for tuberculosis

enthalten in: Wiener klinische Wochenschrift | 2013

von Kurt, O. | Kurt, B. | Talay, F. | +4

6

Monoclonal anti-TNF antibodies can elevate hemoglobin level in patients with ankylosing spondylitis

enthalten in: Rheumatology international | 2013

von Bes, C. | Yazici, A. | Soy, M.

7

Serious menstrual bleeding associated with use of TNF alpha blocker : two cases

enthalten in: Rheumatology international | 2012

von Bes, C. | Soy, M.

8

Can bone quality be predicted accurately by Singh index in patients with rheumatoid arthritis?

enthalten in: Clinical rheumatology | 2012

von Bes, C. | Güven, M. | Akman, B. | +3

9

Pseudo-pseudo Meigs syndrome developed under the leflunomide therapy

enthalten in: Rheumatology international | 2011

von Bes, C. | Soy, M.

10

Risk of cancer in Turkish patients after treatment with TNF antagonists

enthalten in: Rheumatology (Oxford, England) | 2008

von Pay, S. | Society for Research and Education in Rheumatology of Turkey | Oztürk, M. | +24